The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis

Kamyar Kalantar-Zadeh, Elani Streja, Csaba Kovesdy, Antigone Oreopoulos, Nazanin Noori, Jennie Jing, Allen R. Nissenson, Mahesh Krishnan, Joel D. Kopple, Rajnish Mehrotra, Stefan D. Anker

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

Objective: To determine whether dry weight gain accompanied by an increase in muscle mass is associated with a survival benefit in patients receiving maintenance hemodialysis (HD). Patients and Methods: In a nationally representative 5-year cohort of 121,762 patients receiving HD 3 times weekly from July 1, 2001, through June 30, 2006, we examined whether body mass index (BMI) (calculated using 3-month averaged post-HD dry weight) and 3-month averaged serum creatinine levels (a likely surrogate of muscle mass) and their changes over time were predictive of mortality risk. Results: In the cohort, higher BMI (up to 45) and higher serum creatinine concentration were incrementally and independently associated with greater survival, even after extensive multivariate adjustment for available surrogates of nutritional status and inflammation. Dry weight loss or gain over time exhibited a graded association with higher rates of mortality or survival, respectively, as did changes in serum creatinine level over time. Among the 50,831 patients who survived the first 6 months and who had available data for changes in weight and creatinine level, those who lost weight but had an increased serum creatinine level had a greater survival rate than those who gained weight but had a decreased creatinine level. These associations appeared consistent across different demographic groups of patients receiving HD. Conclusion: In patients receiving long-term HD, larger body size with more muscle mass appears associated with a higher survival rate. A discordant muscle gain with weight loss over time may confer more survival benefit than weight gain while losing muscle. Controlled trials of muscle-gaining interventions in patients receiving HD are warranted.

Original languageEnglish (US)
Pages (from-to)991-1001
Number of pages11
JournalMayo Clinic Proceedings
Volume85
Issue number11
DOIs
StatePublished - Jan 1 2010

Fingerprint

Body Size
Renal Dialysis
Obesity
Creatinine
Muscles
Mortality
Weight Gain
Weights and Measures
Survival Rate
Serum
Survival
Weight Loss
Body Mass Index
Nutritional Status
Maintenance
Demography
Inflammation

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. / Kalantar-Zadeh, Kamyar; Streja, Elani; Kovesdy, Csaba; Oreopoulos, Antigone; Noori, Nazanin; Jing, Jennie; Nissenson, Allen R.; Krishnan, Mahesh; Kopple, Joel D.; Mehrotra, Rajnish; Anker, Stefan D.

In: Mayo Clinic Proceedings, Vol. 85, No. 11, 01.01.2010, p. 991-1001.

Research output: Contribution to journalArticle

Kalantar-Zadeh, K, Streja, E, Kovesdy, C, Oreopoulos, A, Noori, N, Jing, J, Nissenson, AR, Krishnan, M, Kopple, JD, Mehrotra, R & Anker, SD 2010, 'The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis', Mayo Clinic Proceedings, vol. 85, no. 11, pp. 991-1001. https://doi.org/10.4065/mcp.2010.0336
Kalantar-Zadeh, Kamyar ; Streja, Elani ; Kovesdy, Csaba ; Oreopoulos, Antigone ; Noori, Nazanin ; Jing, Jennie ; Nissenson, Allen R. ; Krishnan, Mahesh ; Kopple, Joel D. ; Mehrotra, Rajnish ; Anker, Stefan D. / The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. In: Mayo Clinic Proceedings. 2010 ; Vol. 85, No. 11. pp. 991-1001.
@article{cb8f794e7f6643c3ad18cdac54440045,
title = "The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis",
abstract = "Objective: To determine whether dry weight gain accompanied by an increase in muscle mass is associated with a survival benefit in patients receiving maintenance hemodialysis (HD). Patients and Methods: In a nationally representative 5-year cohort of 121,762 patients receiving HD 3 times weekly from July 1, 2001, through June 30, 2006, we examined whether body mass index (BMI) (calculated using 3-month averaged post-HD dry weight) and 3-month averaged serum creatinine levels (a likely surrogate of muscle mass) and their changes over time were predictive of mortality risk. Results: In the cohort, higher BMI (up to 45) and higher serum creatinine concentration were incrementally and independently associated with greater survival, even after extensive multivariate adjustment for available surrogates of nutritional status and inflammation. Dry weight loss or gain over time exhibited a graded association with higher rates of mortality or survival, respectively, as did changes in serum creatinine level over time. Among the 50,831 patients who survived the first 6 months and who had available data for changes in weight and creatinine level, those who lost weight but had an increased serum creatinine level had a greater survival rate than those who gained weight but had a decreased creatinine level. These associations appeared consistent across different demographic groups of patients receiving HD. Conclusion: In patients receiving long-term HD, larger body size with more muscle mass appears associated with a higher survival rate. A discordant muscle gain with weight loss over time may confer more survival benefit than weight gain while losing muscle. Controlled trials of muscle-gaining interventions in patients receiving HD are warranted.",
author = "Kamyar Kalantar-Zadeh and Elani Streja and Csaba Kovesdy and Antigone Oreopoulos and Nazanin Noori and Jennie Jing and Nissenson, {Allen R.} and Mahesh Krishnan and Kopple, {Joel D.} and Rajnish Mehrotra and Anker, {Stefan D.}",
year = "2010",
month = "1",
day = "1",
doi = "10.4065/mcp.2010.0336",
language = "English (US)",
volume = "85",
pages = "991--1001",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "11",

}

TY - JOUR

T1 - The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis

AU - Kalantar-Zadeh, Kamyar

AU - Streja, Elani

AU - Kovesdy, Csaba

AU - Oreopoulos, Antigone

AU - Noori, Nazanin

AU - Jing, Jennie

AU - Nissenson, Allen R.

AU - Krishnan, Mahesh

AU - Kopple, Joel D.

AU - Mehrotra, Rajnish

AU - Anker, Stefan D.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Objective: To determine whether dry weight gain accompanied by an increase in muscle mass is associated with a survival benefit in patients receiving maintenance hemodialysis (HD). Patients and Methods: In a nationally representative 5-year cohort of 121,762 patients receiving HD 3 times weekly from July 1, 2001, through June 30, 2006, we examined whether body mass index (BMI) (calculated using 3-month averaged post-HD dry weight) and 3-month averaged serum creatinine levels (a likely surrogate of muscle mass) and their changes over time were predictive of mortality risk. Results: In the cohort, higher BMI (up to 45) and higher serum creatinine concentration were incrementally and independently associated with greater survival, even after extensive multivariate adjustment for available surrogates of nutritional status and inflammation. Dry weight loss or gain over time exhibited a graded association with higher rates of mortality or survival, respectively, as did changes in serum creatinine level over time. Among the 50,831 patients who survived the first 6 months and who had available data for changes in weight and creatinine level, those who lost weight but had an increased serum creatinine level had a greater survival rate than those who gained weight but had a decreased creatinine level. These associations appeared consistent across different demographic groups of patients receiving HD. Conclusion: In patients receiving long-term HD, larger body size with more muscle mass appears associated with a higher survival rate. A discordant muscle gain with weight loss over time may confer more survival benefit than weight gain while losing muscle. Controlled trials of muscle-gaining interventions in patients receiving HD are warranted.

AB - Objective: To determine whether dry weight gain accompanied by an increase in muscle mass is associated with a survival benefit in patients receiving maintenance hemodialysis (HD). Patients and Methods: In a nationally representative 5-year cohort of 121,762 patients receiving HD 3 times weekly from July 1, 2001, through June 30, 2006, we examined whether body mass index (BMI) (calculated using 3-month averaged post-HD dry weight) and 3-month averaged serum creatinine levels (a likely surrogate of muscle mass) and their changes over time were predictive of mortality risk. Results: In the cohort, higher BMI (up to 45) and higher serum creatinine concentration were incrementally and independently associated with greater survival, even after extensive multivariate adjustment for available surrogates of nutritional status and inflammation. Dry weight loss or gain over time exhibited a graded association with higher rates of mortality or survival, respectively, as did changes in serum creatinine level over time. Among the 50,831 patients who survived the first 6 months and who had available data for changes in weight and creatinine level, those who lost weight but had an increased serum creatinine level had a greater survival rate than those who gained weight but had a decreased creatinine level. These associations appeared consistent across different demographic groups of patients receiving HD. Conclusion: In patients receiving long-term HD, larger body size with more muscle mass appears associated with a higher survival rate. A discordant muscle gain with weight loss over time may confer more survival benefit than weight gain while losing muscle. Controlled trials of muscle-gaining interventions in patients receiving HD are warranted.

UR - http://www.scopus.com/inward/record.url?scp=78149325694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149325694&partnerID=8YFLogxK

U2 - 10.4065/mcp.2010.0336

DO - 10.4065/mcp.2010.0336

M3 - Article

C2 - 21037042

AN - SCOPUS:78149325694

VL - 85

SP - 991

EP - 1001

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 11

ER -